Our top pick for
Bill.com Holdings Inc is a software-application business based in the US. Bill-com shares (BILL) are listed on the NYSE and all prices are listed in US Dollars. Bill-com employs 1,384 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$296.05|
|52-week range||$89.19 - $301.99|
|50-day moving average||$280.70|
|200-day moving average||$200.42|
|Wall St. target price||$287.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.19|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-11)||9.41%|
|1 month (2021-09-17)||0.63%|
|3 months (2021-07-16)||62.66%|
|6 months (2021-04-16)||84.19%|
|1 year (2020-10-16)||155.08%|
|2 years (2019-10-14)||N/A|
|3 years (2018-10-14)||N/A|
|5 years (2016-10-14)||N/A|
|Revenue TTM||$238.3 million|
|Gross profit TTM||$176.8 million|
|Return on assets TTM||-1.47%|
|Return on equity TTM||-6.09%|
|Market capitalisation||$30.2 billion|
TTM: trailing 12 months
There are currently 8.1 million Bill-com shares held short by investors – that's known as Bill-com's "short interest". This figure is 10.7% up from 7.3 million last month.
There are a few different ways that this level of interest in shorting Bill-com shares can be evaluated.
Bill-com's "short interest ratio" (SIR) is the quantity of Bill-com shares currently shorted divided by the average quantity of Bill-com shares traded daily (recently around 1.9 million). Bill-com's SIR currently stands at 4.19. In other words for every 100,000 Bill-com shares traded daily on the market, roughly 4190 shares are currently held short.
However Bill-com's short interest can also be evaluated against the total number of Bill-com shares, or, against the total number of tradable Bill-com shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Bill-com's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Bill-com shares in existence, roughly 80 shares are currently held short) or 0.0958% of the tradable shares (for every 100,000 tradable Bill-com shares, roughly 96 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Bill-com.
Find out more about how you can short Bill-com stock.
We're not expecting Bill-com to pay a dividend over the next 12 months.
Bill. com Holdings, Inc. provides cloud-based software that simplifies, digitizes, and automates back-office financial operations for small and midsize businesses worldwide. It offers artificial intelligence enabled financial software platform that creates seamless connections among users, suppliers, and the clients. The company provides software-as-a-service, cloud-based payments and spend management products, which allow users to automate accounts payable and accounts receivable transactions, as well as enable users to connect with their suppliers and/or customers to do business, eliminate expense reports, manage cash flows, and improve office efficiency. It also offers onboarding implementation support, and ongoing support and training services. The company also serves accounting firms and financial institutions.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.